Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 12/2022

Open Access 30-09-2022 | Obituary

Obituary for Herman D. Suit, M.D., D. Phil.

Authors: Prof. Dr. Michael Baumann, Wilfried Budach, Jürgen Debus

Published in: Strahlentherapie und Onkologie | Issue 12/2022

Login to get access

Excerpt

Herman D. Suit, M.D., D. Phil. (Fig. 1), was among the most important radiation oncologists shaping our discipline, and an honorary member of the Deutsche Gesellschaft für Radioonkologie (DEGRO). In July 2022, Dr. Suit passed away at the age of 93. …
Literature
1.
2.
3.
4.
5.
6.
7.
Herman and Joan Suit Professorship in Radiation Oncology 2001 (2004) In President and Fellows of Harvard College (2004) Harvard University History of Named Chairs: Sketches of Donors and Donations 1991–2004, Cambridge, Massachusetts, pp 578–579
Metadata
Title
Obituary for Herman D. Suit, M.D., D. Phil.
Authors
Prof. Dr. Michael Baumann
Wilfried Budach
Jürgen Debus
Publication date
30-09-2022
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 12/2022
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-022-02004-2

Other articles of this Issue 12/2022

Strahlentherapie und Onkologie 12/2022 Go to the issue

Original Article

Focal cavity radiotherapy after neurosurgical resection of brain metastases: sparing neurotoxicity without compromising locoregional control

Original Article

Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?

Literatur kommentiert

Eine Monotherapie mit Immuncheckpointblockade führt bei Patienten mit Rektumkarzinom und Mikrosatelliteninstabilität zur klinischen Komplettremission

Original Article

Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study

Nachruf

Zur Erinnerung an Prof. Dr. med. Manfred Strietzel

Literatur kommentiert

Boost und Hypofraktionierung beim DCIS